Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Primary Myelofibrosis 12Polycythemia Vera 11Myelodysplastic Syndromes 10Leukemia 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Myeloproliferative Disorders 8Recurrence 6Leukemia, Myelomonocytic, Chronic 6Hematologic Neoplasms 6Breast Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, T-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Graft vs Host Disease 5Thrombocythemia, Essential 4Leukemia, Myeloid, Chronic-Phase 4Triple Negative Breast Neoplasms 3Prostatic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Prolymphocytic, T-Cell 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2

Interventions

Dexamethasone 10Cyclophosphamide 9Cytarabine 7venetoclax 6Vincristine 6Methotrexate 5blinatumomab 4Prednisone 4Inotuzumab Ozogamicin 4Doxorubicin 4Rituximab 3prednylidene 2pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2deltacortene 2Mercaptopurine 2Etoposide 2Decitabine 2Calcium Dobesilate 2trametinib 1ruxolitinib 1olverembatinib 1ofatumumab 1nilotinib 1navitoclax 1fludarabine 1capivasertib 1azathiopurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × ruxolitinib × Clear all
NCT05745714 2025-09-16

HEM-iSMART C

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡